Area of research
Infectious Diseases · Neurology
Research interest
Research interests include COVID-19 Clinical Research Studies, Long-Term Effects of COVID-19, SARS-CoV-2 and COVID-19 Research, and Antimicrobial Resistance in Staphylococcus.
Current sepsis management practices in European emergency departments: the ISG-emergency department European Survey
Rezafungin Utilisation in Real Life-FungiScope Results From Europe and the United States.
Curriculum „Internistische Intensivmedizin und Notfallmedizin“
Back to the wildtype: SARS-CoV-2 evolution in critically ill patients with severe lung failure
Definition of the Post-COVID syndrome using a symptom-based Post-COVID score in a prospective, multi-center, cross-sectoral cohort of the German National Pandemic Cohort Network (NAPKON)
Curriculum Klinische Akut- und Notfallmedizin – Schwerpunkt Innere Medizin
Bioactive adrenomedullin and interleukin-6 in COVID-19: potential biomarkers of acute kidney injury and critical illness
Systematic assessment of COVID-19 host genetics using whole genome sequencing data
Information Mode-Dependent Success Rates of Obtaining German Medical Informatics Initiative-Compliant Broad Consent in the Emergency Department: Single-Center Prospective Observational Study.
Final Study Report of Andexanet Alfa for Major Bleeding With Factor Xa Inhibitors
Schweres therapierefraktäres Lungenversagen bei COVID-19: Stellenwert und Problematik einer Langzeitunterstützung mit ceno-venöser extrakorporaler Membranoxygenierung Eine retrospektive Analyse des ECMO Zentrum Regensburg.
DFV890: a new oral NLRP3 inhibitor—tested in an early phase 2a randomised clinical trial in patients with COVID-19 pneumonia and impaired respiratory function
The German National Pandemic Cohort Network (NAPKON): rationale, study design and baseline characteristics
The German National Pandemic Cohort Network (NAPKON): rationale, study design and baseline characteristics.
Diagnostic value of FDG PET/CT imaging in patients with surgically managed infective endocarditis: results of a retrospective analysis at a tertiary center.
All-cause mortality and disease progression in SARS-CoV-2-infected patients with or without antibiotic therapy: an analysis of the LEOSS cohort.
Niedrige Inzidenz von SARS-CoV‑2-Infektionen bei Krankenhausmitarbeitern eines Maximalversorgers
Correction to: Contribution of High Viral Loads, Detection of Viral Antigen and Seroconversion to Severe Acute Respiratory Syndrome Coronavirus 2 Infectivity
Swarm Learning for decentralized and confidential clinical machine learning
COVID-19–Associated Pulmonary Aspergillosis, March–August 2020
Early IFN-α signatures and persistent dysfunction are distinguishing features of NK cells in severe COVID-19
COVID-19-Associated Pulmonary Aspergillosis, March-August 2020.
Early IFN-α signatures and persistent dysfunction are distinguishing features of NK cells in severe COVID-19.
Epidemiology of SARS-CoV-2.
COVID-19 in cancer patients: clinical characteristics and outcome-an analysis of the LEOSS registry.
A highly specific and sensitive serological assay detects SARS-CoV-2 antibody levels in COVID-19 patients that correlate with neutralization.
First results of the "Lean European Open Survey on SARS-CoV-2-Infected Patients (LEOSS)".
Lack of antibodies against seasonal coronavirus OC43 nucleocapsid protein identifies patients at risk of critical COVID-19
Lack of antibodies against seasonal coronavirus OC43 nucleocapsid protein identifies patients at risk of critical COVID-19.
Neurological symptoms and complications in predominantly hospitalized COVID‐19 patients: Results of the European multinational Lean European Open Survey on SARS‐Infected Patients (LEOSS)